Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001044321-09-000119
Filing Date
2009-05-11
Accepted
2009-05-11 13:32:43
Documents
1
Period of Report
2009-05-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 5174
  Complete submission text file 0001044321-09-000119.txt   7234
Mailing Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022
Business Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022 2122076500
MARXE AUSTIN W & GREENHOUSE DAVID M (Reporting) CIK: 0001044321 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-29173 | Film No.: 09813874

Mailing Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142 617 674 5300
VERENIUM CORP (Issuer) CIK: 0001049210 (see all company filings)

EIN.: 223297375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2860 Industrial Organic Chemicals